【Expert Recommendation】 Samsung Electronics Target Price 80,000 Won? Also Watch the Movements of Beneficiary Stocks

▶Semiconductor Stocks You Must Buy Today or Tomorrow (Click)

Interest in semiconductor stocks is intensifying following the earnings surprise news from Samsung Electronics and SK Hynix.

There had been expectations that the demand for mobile devices would increase due to the rise of untact culture caused by COVID-19 and the expansion of mobility, leading to increased semiconductor supply. Samsung Electronics proved this by recovering an operating profit of 8 trillion KRW.

If the economic recovery continues after COVID-19, even greater profits can be expected in the future, so interest in semiconductor stocks remains strong.

▶Semiconductor Stocks' Earnings Surprises Continue! Which Stocks Benefit? (Click)

The introduction of 5G is expected to accelerate, and PC demand is expected to recover, leading to expanded production capacity.

Moreover, the demand for non-memory semiconductors, which had somewhat contracted, is increasing, showing signs of overall improvement in the semiconductor market conditions.

The performance of major semiconductor manufacturers like Samsung Electronics and SK Hynix proves this, and explosive growth is anticipated.

▶We Will Take Care of Your Profits Until the End. Day Investment Group's 'Never Ending Care' (Click)

Considering future value, semiconductor stocks are ultimately expected to rise about 3 to 4 times compared to this year.

Jeon Jeong-hyun, an expert at Day Investment Group, said, "Semiconductors are just getting started." He added, "Of course, stock prices may stagnate after earnings announcements, but since the bottom is well established, they will rise tremendously. In the end, if you don't buy now, you will definitely regret it."

Meanwhile, if you want to receive information about semiconductor stocks expected to rise significantly, please click the link below.

▶Semiconductor Stocks Every Investor Must Check (Click)

Stocks of interest: Sinseong Tongsang, Aprogen Pharmaceuticals, CMG Pharmaceuticals, Zenen Bio, EDGC

※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.